Manulife (Manufacturers Life Insurance)’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-16,906
| Closed | -$1.16M | – | 2946 |
|
|
2019
Q3 | $1.16M | Sell |
16,906
-194
| -1% | -$13.3K | ﹤0.01% | 1579 |
|
|
2019
Q2 | $995K | Buy |
17,100
+3,006
| +21% | +$178K | ﹤0.01% | 1655 |
|
|
2019
Q1 | $988K | Buy |
14,094
+1,302
| +10% | +$96.5K | ﹤0.01% | 1706 |
|
|
2018
Q4 | $824K | Sell |
12,792
-1,335
| -9% | -$93.6K | ﹤0.01% | 1673 |
|
|
2018
Q3 | $992K | Sell |
14,127
-1,907
| -12% | -$112K | ﹤0.01% | 1803 |
|
|
2018
Q2 | $809K | Buy |
16,034
+322
| +2% | +$12.8K | ﹤0.01% | 2025 |
|
|
2018
Q1 | $492K | Sell |
15,712
-142
| -0.9% | -$4.71K | ﹤0.01% | 2335 |
|
|
2017
Q4 | $542K | Buy |
15,854
+385
| +2% | +$12.3K | ﹤0.01% | 2265 |
|
|
2017
Q3 | $497K | Sell |
15,469
-388
| -2% | -$12.2K | ﹤0.01% | 2280 |
|
|
2017
Q2 | $516K | Buy |
15,857
+520
| +3% | +$16.5K | ﹤0.01% | 2263 |
|
|
2017
Q1 | $483K | Buy |
15,337
+1,743
| +13% | +$51.6K | ﹤0.01% | 2216 |
|
|
2016
Q4 | $400K | Buy |
13,594
+220
| +2% | +$6.71K | ﹤0.01% | 2265 |
|
|
2016
Q3 | $386K | Buy |
13,374
+80
| +0.6% | +$2.23K | ﹤0.01% | 2246 |
|
|
2016
Q2 | $344K | Buy |
13,294
+1,149
| +9% | +$30.5K | ﹤0.01% | 2274 |
|
|
2016
Q1 | $298K | Sell |
12,145
-6
| -0% | -$165 | ﹤0.01% | 2313 |
|
|
2015
Q4 | $428 | Hold |
12,151
| – | – | ﹤0.01% | 2110 |
|
|
2015
Q3 | $258 | Buy |
12,151
+347
| +3% | +$8.94K | ﹤0.01% | 2446 |
|
|
2015
Q2 | $329 | Buy |
11,804
+320
| +3% | +$9.03K | ﹤0.01% | 2438 |
|
|
2015
Q1 | $351 | Buy |
11,484
+427
| +4% | +$13.6K | ﹤0.01% | 2315 |
|
|
2014
Q4 | $353 | Sell |
11,057
-251
| -2% | -$8.17K | ﹤0.01% | 2215 |
|
|
2014
Q3 | $321 | Sell |
11,308
-87
| -0.8% | -$2.43K | ﹤0.01% | 2295 |
|
|
2014
Q2 | $312K | Sell |
11,395
-2,030
| -15% | -$54K | ﹤0.01% | 2389 |
|
|
2014
Q1 | $353 | Sell |
13,425
-55
| -0.4% | -$1.58K | ﹤0.01% | 2313 |
|
|
2013
Q4 | $395 | Buy |
13,480
+321
| +2% | +$10.2K | ﹤0.01% | 2229 |
|
|
2013
Q3 | $403 | Sell |
13,159
-411
| -3% | -$13.7K | ﹤0.01% | 2129 |
|
|
2013
Q2 | $430K | Buy |
+13,570
| New | +$446K | ﹤0.01% | 1987 |
|
Manulife (Manufacturers Life Insurance)'s GHDX Position: Q4 2019 in Review
Manulife (Manufacturers Life Insurance) sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 16,906 shares — an estimated $1.16M sold.
Manulife (Manufacturers Life Insurance) first reported a position in GHDX in Q2 2013 and held it in 26 quarters. The position peaked at $1.16M in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Manulife (Manufacturers Life Insurance) reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Manulife (Manufacturers Life Insurance) sold 16,906 Genomic Health, Inc. shares in Q4 2019, an estimated $1.16M.
- Manulife (Manufacturers Life Insurance) first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 26 quarters.
- Manulife (Manufacturers Life Insurance)'s Genomic Health, Inc. position peaked at $1.16M in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2019, filed 14 Feb 2020.